However the use of ACE2 inhibitors is still challenging, and corticosteroid administration in autoimmune diseases can make it more difficult to diagnose and treat COVID-19 because ACE2 inhibitors prevent fever during the disease. This evidence concerns the gene ACE2 and autoimmune disease.